Novocure Reports First Quarter 2019 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Novocure (NVCR) Tops Q1 EPS by 1c, Revenues Beat
May 2, 2019 6:18 AM EDTNovocure (NASDAQ: NVCR) reported Q1 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $73.31 million versus the consensus estimate of $72.85 million.
With more than 2,600 patients on Optune as of March 31, 2019, we delivered another quarter of strong financial performance. We... More



